InvestorsHub Logo
Followers 706
Posts 31187
Boards Moderated 0
Alias Born 01/27/2005

Re: Skiluc post# 48368

Tuesday, 04/13/2021 2:30:20 PM

Tuesday, April 13, 2021 2:30:20 PM

Post# of 118383
The License IP consists of antigen specific cancer vaccines in which modified mRNA is administered to produce epitopes able to produce an immune response which augments likelihood of successful induction of immunity. An epitope is the part of an antigen that is recognized by the immune system.